StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

1-Aminocyclopentancarbonsäure

Cycloleucine

HCID 2901
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
52-52-8
Standard-SMILES
NC1(C(=O)O)CCCC1
InChIKey
NILQLFBWTXNUOE-UHFFFAOYSA-N
Summenformel
C6H11NO2
Durchschnittliche Molmasse
129,16 g/mol
Monoisotopische Masse
129,07897859

Überblick

1-aminocyclopentanecarboxylic acid is a non-proteinogenic alpha-amino acid that is cyclopentane substituted at position 1 by amino and carboxy groups. It has a role as an EC 2.5.1.6 (methionine adenosyltransferase) inhibitor.

Namen und Bezeichner

Bevorzugter Name
Cycloleucine
IUPAC
1-aminocyclopentane-1-carboxylic acid
Lokaler Name
1-Aminocyclopentancarbonsäure
Englischer Name
Cycloleucine
Summenformel
C6H11NO2
Molmasse
129.16

Namen und Synonyme

cycloleucine52-52-81-Aminocyclopentanecarboxylic acid1-Aminocyclopentane-1-carboxylic acidCycloleucin1-Amino-1-cyclopentanecarboxylic acidCYCLO-LEUCINE1-Amino-1-carboxycyclopentaneCyclopentanecarboxylic acid, 1-amino-1-Amino-cyclopentanecarboxylic acidNSC 1026CB 1639
Weitere Namen anzeigen
1-Carboxycyclopentylaminex201cb1639CYCLEU
1-Aminocyclopentanecarboxylateaminocyclopentanecarboxylic acidX 201NSC1026WR 14,997NSC-10260TQU7668EIAcid, aminocyclopentanecarboxylic

Datenbank-Bezeichner

CAS
52-52-8
PubChem CID
2901
DTXSID
DTXSID5024475
ChEMBL
CHEMBL295830
ChEBI
CHEBI:40547
UNII
0TQU7668EI

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
-2,6
Polarare Oberfläche (TPSA)
63,3 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
1
Schwere Atome
9
Formalladung
0
Komplexität
127

Experimentelle und physikochemische Eigenschaften

Chemical ClassesNitrogen Compounds -> Amino Carboxylic Acids
DrugsPharmaceuticals -> Listed in ZINC15
Color/FormCRYSTALS FROM ETHANOL & WATER
SolubilitySOL IN WATER APPROX 5 G/100 ML
Melting Point330 °C, DECOMP
Physical DescriptionSolid; [Merck Index] Crystalline powder; [Alfa Aesar MSDS]
Stability/Shelf LifeFORMS STABLE METAL SALTS
Dissociation Constants2.62
Collision Cross Section126.23 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
Other Experimental PropertiesMP 274 °C, DECOMP; PRISMIC CRYSTALS FROM WATER /HYDROCHLORIDE/

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H301 (94.2%): Toxic if swallowed [Danger Acute toxicity, oral]

P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 52 reports by companies from 5 notifications to the ECHA C&L Inventory.

Gefahrenhinweise

Hazards Summary · 1 Eintrag

Possesses cytostatic, immunosuppressive, and antineoplastic properties; [ChemIDplus] Evidence of neurotoxicity in experimental animals; [HSDB] Causes urine changes in 3-day intermittent intraperitoneal studies of rats; Causes muscle weakness and hemorrhage in 15-day intermittent intravenous studies of dogs; Oral administration in humans causes anorexia and nausea or vomiting; [RTECS] An irritant; Harmful by ingestion; [Alfa Aesar MSDS]

Hazard Classes and CategoriesAcute Tox. 3 (94.2%)

Toxikologische Informationen

Adverse EffectsNeurotoxin - Other CNS neurotoxin
Non-Human Toxicity Excerpts · 5 Einträge

WHEN ADDED TO CHICK EMBRYO FIBROBLAST CULTURES WHICH HAD BEEN INFECTED WITH AVIAN SARCOMA VIRUS, CYCLOLEUCINE DID NOT SIGNIFICANTLY AFFECT VIRUS YIELDS BUT INHIBITED METHYLATION OF VIRAL RNA AT 5'-TERMINAL STRUCTURES.

IN BHK CELLS INFECTED WITH VESICULAR STOMATITIS VIRUS (VSV), CYCLOLEUCINE INHIBITED VIRUS SYNTHESIS BY 99% & REDUCED SIGNIFICANTLY THE SIZE OF VSV MESSENGER RNA SPECIES.

TREATMENT OF DEVELOPING RATS RESULTED IN CHANGES OF BRAIN & SPINAL CORD PHOSPHOLIPID CONTENT & FATTY ACIDS. DECR IN ETHANOLAMINE PHOSPHOLIPID CONTENT & INCR IN SATURATED FATTY ACIDS OF ETHANOLAMINE PHOSPHOLIPID. MINOR FATTY ACIDS CHANGES IN PHOSPHATIDYL CHOLINE.

Chemie und Industrie

Pharmakologische Informationen

PharmacodynamicsCycloleucine has cytostatic, immunosuppressive and antineoplastic activities.
Mechanism of ActionSYNTHETIC AMINO ACID THOUGHT TO ACT AS VALINE ANTAGONIST.
Biological Half-LifeAT 0.4-0.5 MG/G PLASMA LEVEL AT 24 DAYS WAS NOT SIGNIFICANTLY DIFFERENT FROM THAT AT 1 DAY. HIGHEST DOSES (1-3 MG/G) RESULTED IN NEARLY SIMILAR PLASMA LEVELS BY 4TH DAY. T/2 IN PLASMA WAS EXTREMELY LONG.
Absorption, Distribution and Excretion · 2 Einträge

LEVELS OF (14)C IN LIVER & PANCREAS WERE RESPECTIVELY EIGHTFOLD & TWOFOLD THOSE IN BLOOD, 15 MIN AFTER IV DOSE OF [(14)C]-1-AMINOCYCLOPENTANECARBOXYLIC ACID TO RHESUS MONKEYS. (14)C LEVELS IN THESE TISSUES WERE SIMILAR TO THOSE IN BLOOD AFTER 24 HR.

WHEN ADMIN TO MICE CYCLOLEUCINE ACCUM IN TISSUES AT LEVELS BETWEEN 0.02 & 1.29 MG/ML. MOST OF REMAINING 2% WAS ASSOC WITH PROTEIN. ACCUM AGAINST CONCN GRADIENT OCCURRED IN KIDNEY, IN SPLEEN TO GREATER EXTENT & TO MUCH GREATER DEGREE IN PANCREAS. THE DISTRIBUTION RATIOS FOR CNS TISSUE, KIDNEY & SPLEEN DID NOT CHANGE AS FUNCTION OF PLASMA CYCLOLEUCINE CONCN OR OF TIME BETWEEN 4 & 40 DAYS AFTER ADMIN TO MICE. 5 DAYS AFTER ADMIN OF CYCLOLEUCINE TO MICE, HEPATIC CYCLOLEUCINE DISTRIBUTION RATIO WAS CONSIDERABLY GREATER THAN UNITY AT THE LOWEST DOSES & INCR VARIABLY WITH INCR CYCLOLEUCINE PLASMA LEVELS.

Verwendung und Herstellung

Uses · 4 Einträge

A synthetic amino acid used in amino acid transport studies and in testing for immunosuppression in mice; [Merck Index] Used as experimental tumor screening agent; [HSDB]

BIOLOGICAL TESTING MATERIALS FOR IMMUNOSUPPRESSIVE PROPERTIES IN MICE; FOR AMINO ACID TRANSPORT STUDIES

AS EXPTL TUMOR SCREENING AGENT

MEDICATION (VET)

Methods of Manufacturing · 1 Eintrag

ZELINSKY, STADNIKOFF, Z PHYSIOL CHEM 75, 350 (1911); CONNORS, ROSS, J CHEM SOC 1960, 2119; CREMLYN, J CHEM SOC 1962, 3977; SUDO, ICHIHARA, BULL CHEM SOC JAPAN 36, 34 (1963). MFR: NETHERLAND PATENT APPLICATION 6,607,754 (1966 TO ROHM & HAAS), CA 67, 73159B (1967).

Zugehörige Reaktionen

43
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 166662
HRID 166662als Edukt
Reaktionsgleichung von HRID 181100
HRID 181100als Edukt
Reaktionsgleichung von HRID 254030
HRID 254030als Edukt
Reaktionsgleichung von HRID 276253
HRID 276253als Edukt
Reaktionsgleichung von HRID 276694
HRID 276694als Edukt
Reaktionsgleichung von HRID 276695
HRID 276695als Edukt
Reaktionsgleichung von HRID 276697
HRID 276697als Edukt
Reaktionsgleichung von HRID 276699
HRID 276699als Edukt
ZurückSeite 1 von 6

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
EC Number
200-144-6
Nikkaji
J4.131I

Physikochemische Eigenschaften

Schmelzpunkt
320 °C · 320 °C (dec.) (lit.)
Siedepunkt
239.22 °C · 239.22°C (rough estimate)
Dichte
1.1426 · 1.1426 (rough estimate)
Brechungsindex
1.4827 · 1.4827 (estimate)
storage temp.
Keep in dark place,Inert atmosphere,Room temperature
Löslichkeit
1 mg/mL · DMSO: < 1 mg/mL (ultrasonic) (insoluble or slightly soluble)
pka
2.38 · 2.38±0.20(Predicted)
Aggregatzustand
Crystalline Flakes or Powder
Farbe
White to beige
Wasserlöslichkeit
5 g/100 · 5 g/100 mL
Merck
14 · 14,2734
BRN
636626 · 636626
Major Application
peptide synthesis
InChI
1S/C6H11NO2/c7-6(5(8)9)3-1-2-4-6/h1-4,7H2,(H,8,9)
InChIKey
NILQLFBWTXNUOE-UHFFFAOYSA-N
SMILES
NC1(CCCC1)C(O)=O
CAS Datenbank
52 · 52-52-8(CAS DataBase Reference)
NIST chemische Informationen
1 · Cyclopentanecarboxylic acid, 1-amino-(52-52-8)
EPA chemische Informationen
1 · Cyclopentanecarboxylic acid, 1-amino- (52-52-8)

CONSIDERABLE MYELIN SPLITTING WAS SHOWN BY ELECTRON MICROSCOPIC EXAMINATION OF THE SPINAL CORDS OF CYCLOLEUCINE-AFFECTED RATS.

For more Non-Human Toxicity Excerpts (Complete) data for CYCLOLEUCINE (10 total), please visit the HSDB record page.

Sicherheitsdaten

wgk
3
tsca
TSCA listed
ridadr
UN 2811 6.1/PG 3
hs_code
29224999
RTECS-Nr.
GY2625000
risk_code
22
Toxizität
LD50 oral in rat: 290mg/kg
hazard_code
Xn,Xi
safety_code
22-24/25
hazard_class
6.1
packing_group
III
Speicherklasse
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Giftige Stoffe Daten
52-52-8(Hazardous Substances Data)
Hazard Classifications
Acute Tox. 3 Oral
General Manufacturing InformationCyclopentanecarboxylic acid, 1-amino-: ACTIVE

Anwendungen

VerwendenCycloleucine is a synthetic amino acid used in numerous biochemical transport studies

Vor- und nachgelagerte Produkte

Nachgelagerte Produkte

Methyl 1-amino-1-cyclopentanecarboxylateMethyl 1-amino-1-cyclopentanecarboxylate hydrochloride

Ergänzende Hinweise

DefinitionChEBI: A non-proteinogenic alpha-amino acid that is cyclopentane substituted at position 1 by amino and carboxy groups.